Lymphopenia News and Research

RSS
Lymphopenia is a condition in which there is a lower-than-normal number of lymphocytes (a type of white blood cell) in the blood. Also called lymphocytic leukopenia and lymphocytopenia.
FDA approves first therapy for patients with rare tumors of the adrenal gland

FDA approves first therapy for patients with rare tumors of the adrenal gland

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

Trial shows safety, feasibility of adding immunotherapy during chemoradiation for head and neck cancer

Trial shows safety, feasibility of adding immunotherapy during chemoradiation for head and neck cancer

Scientists discover how gene mutation affects T cell function to promote immune disorders

Scientists discover how gene mutation affects T cell function to promote immune disorders

FDA approves new radioactive drug for treatment of rare digestive tract cancers

FDA approves new radioactive drug for treatment of rare digestive tract cancers

First-ever treatment for Merkel cell carcinoma receives approval in Japan

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Research finds new therapeutic strategy to prevent infections in spinal cord injury patients

Research finds new therapeutic strategy to prevent infections in spinal cord injury patients

Small clinical trial reveals promising results of triple immunotherapy in treating rare skin cancer

Small clinical trial reveals promising results of triple immunotherapy in treating rare skin cancer

Merck presents data on investigational cladribine tablets in relapsing multiple sclerosis

Merck presents data on investigational cladribine tablets in relapsing multiple sclerosis

Vaccine-chemotherapy combination may improve survival for glioblastoma patients

Vaccine-chemotherapy combination may improve survival for glioblastoma patients

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

Clinical study shows improved outcomes for NET patients treated with Lutathera over Octreotide LAR

Clinical study shows improved outcomes for NET patients treated with Lutathera over Octreotide LAR

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Lenalidomide trials show potential for expanding lymphoma, leukaemia indications

Lenalidomide trials show potential for expanding lymphoma, leukaemia indications

FDA grants accelerated approval for Darzalex to treat patients with multiple myeloma

FDA grants accelerated approval for Darzalex to treat patients with multiple myeloma

New combination treatment approved by FDA for metastatic pancreatic cancer

New combination treatment approved by FDA for metastatic pancreatic cancer

Interim data from long-term extension Tecfidera® (dimethyl fumarate) study

Interim data from long-term extension Tecfidera® (dimethyl fumarate) study

New diagnostic criteria can help distinguish malignant cancerous chest cavity masses from histoplasmosis

New diagnostic criteria can help distinguish malignant cancerous chest cavity masses from histoplasmosis

Researchers discover role of RORC mutations in patients with candidiasis and mycobacteriosis

Researchers discover role of RORC mutations in patients with candidiasis and mycobacteriosis

Novartis presents positive Phase III results of Farydak therapy at EHA

Novartis presents positive Phase III results of Farydak therapy at EHA